You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Services
    Delivery models
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Medical device approved for Hearing Loss

Background

A Hearing Device sponsor needed Food & Drug Administration (FDA) approval to get their device on the US market. Keyrus Life Science had done a pilot study with the sponsor in conjunction with a CRO in France. The sponsor was happy with the work being done and asked KLS to continue in partnership.

Challenge

For the sponsor device study, only one study needed to be done for regulatory approval. That study was done in Canada. The device was approved in Canada. The challenge for their planned phase IV in the USA became: would data from Canada be enough for approval in USA? We helped them in supporting FDA submission, Sponsor's FDA Approval Process and improving site relationships based on sponsor's issues in past studies

Approach

Keyrus Life Science randomized all patients, gathered quality data, and prepared documents for FDA submission.

Key results

01
Strong Regulatory Documentation
02
Device approved in United States
03
Strong partnership developed between Keyrus Life Science and the sponsor

Benefits

Having learned from the pilot study, the sponsor believed the experience Keyrus Life Science had in Regulatory Affairs would be of benefit to their study.

Share this key play

whatsapptwitter
linkedinfacebookworkplace

Ready for your own success story?

Get in touch with our team of experts.



I acknowledge having read the privacy policy.

Keyrus collects and processes the data you fill out in this form in order to respond to your request and for commercial prospecting purposes. The fields marked with an asterisk must be filled in for your request to be processed. To learn more about how we manage your personal data and to exercise your rights, please refer to the Privacy Policy. By clicking on Submit, I acknowledge that I have read and accepted the legal notice and the general terms of use of the site.

More key plays

Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Speed up the development of clinical study documents
Transforming pediatric care through digital enablement
Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Managing efficiently a large cohort RWE study, thanks to dedicated apparatus
Logo - Kls
Headquarters

155 rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

Fax:+33 (0)1 41 34 10 10

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection